{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial of the Dor Procedure with Intraoperative Substrate Mapping for Refractory Ventricular Tachycardia"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "Participants were randomised to receive either the Dor procedure with intraoperative substrate mapping and ablation or standard care."
      },
      "Participants": {
        "score": 2,
        "evidence": "Eligible participants were patients with drug-resistant recurrent VT and LV aneurysms."
      },
      "Intervention": {
        "score": 2,
        "evidence": "Participants were randomised to receive either the Dor procedure with intraoperative substrate mapping and ablation or standard care."
      },
      "Objective": {
        "score": 1,
        "evidence": "The study aimed to evaluate the effectiveness of the Dor procedure combined with intraoperative substrate mapping and ablation in patients with left ventricular (LV) aneurysms and refractory ventricular tachycardia (VT)."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was VT recurrence, measured over a 28-month follow-up period."
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was performed using a computer-generated sequence, and allocation was concealed using sealed envelopes."
      },
      "Blinding": {
        "score": 0,
        "evidence": "Blinding was not feasible due to the nature of the intervention."
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "A total of 2 participants were randomised, with 1 in each group."
      },
      "Number_Analysed": {
        "score": 1,
        "evidence": "Both participants were analysed per protocol."
      },
      "Result_Outcome": {
        "score": 2,
        "evidence": "The intervention group showed no VT recurrence at 28 months, while the control group experienced VT recurrence."
      },
      "Harms": {
        "score": 1,
        "evidence": "No major complications were reported in either group."
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Trial registration: Not provided."
      },
      "Funding": {
        "score": 0,
        "evidence": "Funding: Not reported."
      }
    },
    "total_score": 16,
    "max_score": 25
  },
  "model": "gpt-4o"
}